Skip to main content
. 2006 Dec 5;96(1):143–150. doi: 10.1038/sj.bjc.6603501

Figure 4.

Figure 4

Impact of HPV 16/18 vaccine on HPV and cervical cancer epidemiology in the UK. (A) Oncogenic HPV prevalence; (B) CIN 1 prevalence; (C) CIN 2+CIN 3 prevalence; (D) cervical cancer incidence.